The Production Assay Scientist is an enthusiastic, self-motivated individual with great communication skills who can support the Manufacturing, Clinical Laboratory, and Service Engineering groups by working to continuously monitor and improve first pass assay yield for all of our Production grade assays. As a Production Assay Scientist at Counsyl, you will use your deep knowledge of molecular biology and next generation sequencing to actively monitor the health of each one of our production grade assays, and work with multiple groups to implement modifications to the workflow that will improve assay quality. You will be heavily involved in the day to day monitoring of the production assays, as well as ensuring that Counsyl maintains and improves upon our high standards of delivering quality results to our patients in a timely manner, by continuously working to implement both scientific and process based improvements to our current assays and systems.
The Production Assay Scientist will demonstrate a high level of individual responsibility and accountability and possess the ability to perform to the requirements listed below. The candidate will be comfortable performing root cause analyses in a clinical genomics setting, as well as devising and executing scientific experiments to generate data, draw insightful inferences, and implement process improvements.
Counsyl is a health technology company that offers DNA screening for diseases that can impact men, women and their children. The Counsyl philosophy is simple: screen for diseases where advanced knowledge makes a difference in health outcomes, whether it’s changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead.
The Counsyl team includes an accomplished group of problem-solvers — top engineers, scientists, and designers — who are taking the lead on building the modern clinical laboratory. Scientific rigor, custom robotics, and software are at the heart of every Counsyl product, resulting in better, faster and more affordable screens that are broadly accessible. Beyond the laboratory, Counsyl offers doctors and patients a technology platform for results delivery in real time, with on-demand access to board-certified genetic counselors.
Counsyl has screened more than 750,000 patients and served more than 7,000 health care professionals in its CLIA-certified, CAP-accredited and NYS CLEP-permitted clinical laboratory. The company has raised a total of $102 million and is privately backed by Pilot Growth Equity, Goldman Sachs Asset Management, Founders Fund, Felicis Ventures, David Drummond, and other high profile investors.